AFP can activate the PI3K/AKT signalling, stimulates the transcription cofactor mTOR, STAT3, HIF‐1α and Bcl‐2, which regulates the expression of oncogenes, as well as promotes angiogenesis and the growth of the hepatoma cells. The gene discussed is BCL2; the disease is hepatocellular carcinoma.